BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34069262)

  • 1. Mass Spectrometry-Based Glycoproteomics and Prostate Cancer.
    Gabriele C; Prestagiacomo LE; Cuda G; Gaspari M
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissues.
    Li Y; Tian Y; Rezai T; Prakash A; Lopez MF; Chan DW; Zhang H
    Anal Chem; 2011 Jan; 83(1):240-5. PubMed ID: 21141837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012.
    Leymarie N; Griffin PJ; Jonscher K; Kolarich D; Orlando R; McComb M; Zaia J; Aguilan J; Alley WR; Altmann F; Ball LE; Basumallick L; Bazemore-Walker CR; Behnken H; Blank MA; Brown KJ; Bunz SC; Cairo CW; Cipollo JF; Daneshfar R; Desaire H; Drake RR; Go EP; Goldman R; Gruber C; Halim A; Hathout Y; Hensbergen PJ; Horn DM; Hurum D; Jabs W; Larson G; Ly M; Mann BF; Marx K; Mechref Y; Meyer B; Möginger U; Neusüβ C; Nilsson J; Novotny MV; Nyalwidhe JO; Packer NH; Pompach P; Reiz B; Resemann A; Rohrer JS; Ruthenbeck A; Sanda M; Schulz JM; Schweiger-Hufnagel U; Sihlbom C; Song E; Staples GO; Suckau D; Tang H; Thaysen-Andersen M; Viner RI; An Y; Valmu L; Wada Y; Watson M; Windwarder M; Whittal R; Wuhrer M; Zhu Y; Zou C
    Mol Cell Proteomics; 2013 Oct; 12(10):2935-51. PubMed ID: 23764502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.
    Ideo H; Kondo J; Nomura T; Nonomura N; Inoue M; Amano J
    Sci Rep; 2020 Feb; 10(1):2708. PubMed ID: 32066783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry based glycoproteomics--from a proteomics perspective.
    Pan S; Chen R; Aebersold R; Brentnall TA
    Mol Cell Proteomics; 2011 Jan; 10(1):R110.003251. PubMed ID: 20736408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designation of fingerprint glycopeptides for targeted glycoproteomic analysis of serum haptoglobin: insights into gastric cancer biomarker discovery.
    Lee J; Hua S; Lee SH; Oh MJ; Yun J; Kim JY; Kim JH; Kim JH; An HJ
    Anal Bioanal Chem; 2018 Feb; 410(6):1617-1629. PubMed ID: 29285644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary biomarkers in prostate cancer detection and monitoring progression.
    Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
    Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile.
    Vermassen T; D'Herde K; Jacobus D; Van Praet C; Poelaert F; Lumen N; Callewaert N; Decaestecker K; Villeirs G; Hoebeke P; Van Belle S; Rottey S; Delanghe J
    J Clin Pathol; 2017 Oct; 70(10):838-846. PubMed ID: 28360190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation of prostate specific antigen and its potential diagnostic applications.
    Vermassen T; Speeckaert MM; Lumen N; Rottey S; Delanghe JR
    Clin Chim Acta; 2012 Oct; 413(19-20):1500-5. PubMed ID: 22722018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-lectin Affinity Chromatography and Quantitative Proteomic Analysis Reveal Differential Glycoform Levels between Prostate Cancer and Benign Prostatic Hyperplasia Sera.
    Totten SM; Adusumilli R; Kullolli M; Tanimoto C; Brooks JD; Mallick P; Pitteri SJ
    Sci Rep; 2018 Apr; 8(1):6509. PubMed ID: 29695737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An In-Depth Glycosylation Assay for Urinary Prostate-Specific Antigen.
    Kammeijer GSM; Nouta J; de la Rosette JJMCH; de Reijke TM; Wuhrer M
    Anal Chem; 2018 Apr; 90(7):4414-4421. PubMed ID: 29502397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of aggressive prostate cancer associated glycoproteins in urine using glycoproteomics and mass spectrometry.
    Jia X; Chen J; Sun S; Yang W; Yang S; Shah P; Hoti N; Veltri B; Zhang H
    Proteomics; 2016 Dec; 16(23):2989-2996. PubMed ID: 27749016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoproteomics: identifying the glycosylation of prostate specific antigen at normal and high isoelectric points by LC-MS/MS.
    Song E; Mayampurath A; Yu CY; Tang H; Mechref Y
    J Proteome Res; 2014 Dec; 13(12):5570-80. PubMed ID: 25327667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on core-fucosylated prostate-specific antigen as a refined biomarker for differentiation of benign prostate hyperplasia and prostate cancer of different aggressiveness.
    Lang R; Rolny V; Leinenbach A; Karl J; Swiatek-de Lange M; Kobold U; Schrader M; Krause H; Mueller M; Vogeser M
    Tumour Biol; 2019 Mar; 41(3):1010428319827223. PubMed ID: 30907281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry-based expression profiling of clinical prostate cancer.
    Wright ME; Han DK; Aebersold R
    Mol Cell Proteomics; 2005 Apr; 4(4):545-54. PubMed ID: 15695425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer proteomics.
    Masters JR
    OMICS; 2011 Mar; 15(3):169-71. PubMed ID: 21319990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis - mass spectrometry.
    Moran AB; Domínguez-Vega E; Nouta J; Pongracz T; de Reijke TM; Wuhrer M; Lageveen-Kammeijer GSM
    J Proteomics; 2021 Apr; 238():104148. PubMed ID: 33618028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics in diagnosis of prostate cancer.
    Davalieva K; Polenakovic M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass Spectrometry-Based Chemical and Enzymatic Methods for Global Analysis of Protein Glycosylation.
    Xiao H; Suttapitugsakul S; Sun F; Wu R
    Acc Chem Res; 2018 Aug; 51(8):1796-1806. PubMed ID: 30011186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass Spectrometry-Based Glycoproteomic Workflows for Cancer Biomarker Discovery.
    Doud EH; Yeh ES
    Technol Cancer Res Treat; 2023; 22():15330338221148811. PubMed ID: 36740994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.